Strata Critical Medical (SRTA) Research & Development (2020 - 2025)
Strata Critical Medical (SRTA) posted quarterly Research & Development of $453000.0 for Q3 2025, up 44.27% year-over-year from $314000.0 in Q3 2024, and down 72.28% quarter-over-quarter from $1.6 million in Q2 2025.
Strata Critical Medical (SRTA) Research & Development (2020 - 2025) Analysis & Trends
Strata Critical Medical (SRTA) has reported Research & Development for 6 consecutive years, with $453000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Research & Development rose 44.27% year-over-year to $453000.0; the TTM figure through Sep 2025 stood at $10.4 million (up 58105.56% YoY), while the FY2024 annual figure was $8.0 million, up 71.82% from the prior year.
- Research & Development slipped to $453000.0 in Q3 2025 per SRTA's latest filing, from $1.6 million in the prior quarter.
- Across five years, Research & Development topped out at $6.9 million in Q4 2024 and bottomed at -$3.4 million in Q4 2023.
- Historically, Research & Development has averaged $1.4 million across 5 years, with a median of $1.4 million in 2023.
- On a YoY basis, Research & Development climbed as much as 303.62% in 2024 and fell as far as 88.31% in 2024.
- Strata Critical Medical's Research & Development stood at $1.5 million in 2021, then surged by 30.29% to $1.9 million in 2022, then slumped by 279.12% to -$3.4 million in 2023, then jumped by 303.62% to $6.9 million in 2024, then sank by 93.45% to $453000.0 in 2025.
- Business Quant data shows SRTA's Research & Development at $453000.0 in Q3 2025, $1.6 million in Q2 2025, and $1.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | - |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | - |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | - |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | - |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | - |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | - |
| 10 | Strata Critical Medical | 521.95 Mn | 499.20 Mn | 15.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 453,000.00 |
| Jun 30, 2025 | 1.63 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 6.92 Mn |
| Sep 30, 2024 | 314,000.00 |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 670,000.00 |
| Dec 31, 2023 | -3.40 Mn |
| Sep 30, 2023 | 2.69 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Jun 30, 2022 | 1.90 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Jun 30, 2021 | 555,000.00 |
| Mar 31, 2021 | 587,000.00 |
| Jun 30, 2020 | 220,000.00 |